• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • PRODUCT LIBRARY

No Sales, No Company — It’s That Simple!

May 2, 2025 By SPINEMarketGroup

This morning I came across an article on LinkedIn that I found genuinely insightful ( The Back Office Reality of Sales Compensation by Mike Kosikas ). It offered a well-structured explanation of how commercial compensation plans are built — the logic behind protecting margins, evolving incentive schemes, and balancing budgets. It made solid points and reflected the challenges companies face today.

That said, I’d like to add a perspective that sometimes gets overlooked: sales is not just another department. And we shouldn’t treat it as such.

Sales is not an appendix — it’s the engine.

Nothing moves in a company until someone sells something. There’s no production, no logistics, no invoicing, no support. Everything starts with a sale. Sales is not an outcome of business activity — it’s the trigger. That’s why sales compensation shouldn’t be seen as a cost to contain, but as an investment to fuel growth.

When compensation plans are designed with too much financial caution and too little business vision, the result is predictable: disengagement. A team that doesn’t believe their effort has a real impact on their reward will slowly disconnect.

From simple schemes to overcomplicated structures

Many experienced sales professionals reflect on simpler times: clear targets, direct commissions, and bonuses for going above and beyond. Today, incentive plans are increasingly filled with accelerators, caps, penalties, multipliers, and exceptions that make it hard to understand what you’ll earn.

Finance teams often have valid reasons — margins are tight, costs are rising — but we mustn’t forget a basic truth: if you sell more, more comes in. Having to pay higher commissions because you’re exceeding targets should be a reason to celebrate, not a problem to fix.

“But what if everyone overachieves?”

This is a question I’ve heard more than once: “What if everyone over-delivers? What happens to the budget?”

Well, here’s an idea — celebrate it. It means the team is performing, the strategy is working, and the market is responding. The challenge shouldn’t be how to limit success. It should be how to sustain and scale it.

A motivated sales rep is a force of nature.

The best salespeople open doors, defend pricing, build trust, and create long-term relationships that drive growth — even in difficult markets. But they can only do this if they feel genuinely valued. Not just with encouraging words, but with a compensation structure that is fair, motivating, and transparent.

If the plan is too complex to follow, if it feels like they’re penalized for doing well, or if the reward doesn’t reflect the effort, one thing becomes clear: they’re not truly being valued.

Bottom line: paying well isn’t a luxury — it’s a necessity

Sales is the engine. And no engine runs well if you choke it. Companies that want to grow need motivated, committed, and well-compensated sales teams. Because top sales talent goes where it’s recognized, and where it isn’t, it leaves.

###

Related Posts:

  • Why are Sales Reps a key piece in the success of the…
  • The Unsung Guardians of the OR
  • Former Spine Sales Rep from Depuy Synthes Arrested…

Filed Under: ARTICLES, NEWS Tagged With: 2025

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMED newLOGO-min
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
TSUNAMI MEDICAL
syntropiq logo
A-SPINE
L&Kmodelo log

POPULAR POST LAST 90 DAYS

  • DePuy Synthes for Sale: Who Could Actually Buy the…
  • Globus Medical: Stronger in Spine, but Could DePuy…
  • BROCHURES
  • PRODUCT LIBRARY
  • Why Spine’s Commercial Model Needs a Reset? The real…
  • What Is Medtronic’s PILAR™ Technique?
  • Boston Scientific Puts $1.5 Billion on MiRus: Why…
  • Globus Medical: Strong Q1, Weak Stock Reaction — Is…
  • (2025 Update): Market, Leading FDA-Approved Devices,…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • COMPANIES
  • Single-Use Spine Surgery Systems: The Future or…
  • Modular Pedicle Screws: When Adaptability Becomes…
  • BoxSPINE Receives FDA Clearance for Rodless Spinal…
  • (UPDATED 2026) More Than 100 Options, No Single…
  • Orthofix Realigns Spine Leadership to Strengthen…
  • Globus Medical’s Strategy: Building a Closed-Loop…
  • Cervical Fusion Implant Denials: Why Spine Societies…
  • Top 60+ Minimally Invasive Sacroiliac Joint Fusion…
  • VB Spine Announces VB Spine Solutions, a…
  • VB Spine Announces Successful First Clinical Cases…
  • From Early Innovations to Modern Practice: Where Are…
  • Hospital Access Is Gone. What Comes Next for Spine…
  • Johnson & Johnson Explores Potential $20B Sale…
  • ATEC’s Valence: Robotics in Service of a Procedural Strategy
  • Orthofix Discontinues M6-C™ and M6-L™ Artificial…
  • Expandable cages were adopted not because they fused…
  • Globus Medical Reports First Quarter 2026 Results
  • Sublaminar Bands in Spine Surgery: Why This Small…
  • Autonomous Pedicle Screw Placement: Is Spine…
  • LAST 5 VIDEOS PUBLISHED

    1. Syntropiq: Lyra
    2. ATEC Spine: SafeOp®
    3. REACH Medical: Expandable PLIF/TLIF Cage
    4. Expanding Innovations: X-PAC®TLIF 
    5. SI-BONE: iFuse INTRA Ti™ Implant System

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal
    • PRODUCT LIBRARY

    Copyright © 2026 · SPINEMarketGroup